Interestingly, three of the genes with the most common and penetrant ALS mutations known (TARDBP, FUS, and SOD1) depict drug targets, however, their interaction type is not categorized and thus they are not shown in the network (Figure 5). The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.